Why the study?
Does bepridil started at 100 mg/day improve the maintenance of sinus rhythm in patients with persistent atrial fibrillation after failed electrical cardioversion?
Does bepridil started at 100 mg/day improve the maintenance of sinus rhythm in patients with persistent atrial fibrillation after failed electrical cardioversion?
Bepridil initiated at 100 mg/day appears to be an effective and safe strategy for restoring and maintaining sinus rhythm in patients with persistent atrial fibrillation who have failed electrical cardioversion.
May support bepridil for sinus rhythm maintenance after failed cardioversion; leaves open need for randomized confirmation.
Introduction: Bepridil is effective for atrial fibrillation (AF), but it can induce torsades de pointes. Thus we examined the efficacy and safety of bepridil when started at 100 mg/day for AF after failed electrical cardioversion (EC). Methods and Results: We studied 28 consecutive patients (58 ± 12 years old) with failed EC. After administration of bepridil, we examined the time to restore the sinus rhythm, the duration of the maintained sinus rhythm. Our patients were divided into the two groups and various clinical factors were compared, including medication and echocardiographic and electrocardiographic parameters: the SR group who maintained sinus rhythm during followup period and the AF group who still had AF. Sixteen patients (57%) could maintain sinus rhythm (SR group). Adverse arrhythmic events were not observed. There were no significant differences in any clinical factors between the two groups before and after bepridil. Conclusions: Bepridil was effective and safe for persistent AF with failed EC.
No takes yet. Share an insight, caveat, or question.
Egami et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: